REGN

Sanofi-Aventis colorectal cancer drug secures FDA approval in important step for cancer unit

A colorectal cancer drug developed by Sanofi-Aventis (NYSE:SNY) and Regeneron Pharmaceuticals (NASDAQ:REGN) has received approval from the U.S. Food and Drug Administration. Zaltrap is designed to be used in combination with folinic acid, fluorouracil and irinotecan, a commonly used chemotherapy treatment for adults, according to an FDA statement. The drug interferes with blood supply to […]

By Stephanie Baum

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

By PurpleLab

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.